Komori
CellSource (4880) · RiskRestated

Dependence on the Representative Director and President

First written in FY2019. 3 of 4 entries say "Restated". Latest entry: FY2022.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20222020: 120202021: 120212022: 120222023: 1
Same theme, other companies
Dependence on key executivesA theme 560 companies write about · 560 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 10 of 77 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 560 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「We have introduced an executive officer system and are transferring authority through the introduction of a divisional structure and expanded staffing, among other measures, to establish a management structure that does not depend excessively on him.」

    While recognising the Company's dependence on the Representative Director and President, the policy of reducing this dependence through the executive officer system, divisional structure and transfer of authority remains ongoing.
  2. FY2021RestatedAnnual report

    「We have introduced an executive officer system and are transferring authority through expanded staffing and other measures to establish a management structure that does not depend excessively on him.」

    While recognising the Company's dependence on the Representative Director and President, the policy of reducing this dependence through the executive officer system and the transfer of authority remains ongoing.
  3. FY2020RestatedAnnual report

    「Tsutsumoto Rihito (裙本 理人), the Company's Representative Director and President, is the Company's founder and has played an important role in formulating and determining management policies and business strategies and advancing the business as a Representative Director since the Company's establishment.」

    While recognising the Company's dependence on the Representative Director and President, the Company has indicated a policy of assigning directors and executive officers responsible for business operations and transferring authority.
  4. FY2019First statedAnnual report

    「Tsutsumoto Rihito (裙本 理人), the Company's Representative Director and President, is the Company's founder and has played an important role in formulating and determining management policies and business strategies and advancing the business as a Representative Director since the Company's establishment.」

    Although the Company is assigning directors responsible for business operations and transferring authority, the impact if the President becomes unable to advance the business is identified as a risk.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for CellSource yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.